[go: up one dir, main page]

US20170189175A1 - Artificial, flexible valves and methods of fabricating and serially expanding the same - Google Patents

Artificial, flexible valves and methods of fabricating and serially expanding the same Download PDF

Info

Publication number
US20170189175A1
US20170189175A1 US15/308,667 US201515308667A US2017189175A1 US 20170189175 A1 US20170189175 A1 US 20170189175A1 US 201515308667 A US201515308667 A US 201515308667A US 2017189175 A1 US2017189175 A1 US 2017189175A1
Authority
US
United States
Prior art keywords
leaflets
stent
valve
canceled
mandrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/308,667
Other languages
English (en)
Inventor
Henri Justino
Daniel Harrington
Kwonsoo Chun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
William Marsh Rice University
Original Assignee
Baylor College of Medicine
William Marsh Rice University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine, William Marsh Rice University filed Critical Baylor College of Medicine
Priority to US15/308,667 priority Critical patent/US20170189175A1/en
Publication of US20170189175A1 publication Critical patent/US20170189175A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/243—Deployment by mechanical expansion
    • A61F2/2433—Deployment by mechanical expansion using balloon catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415—Manufacturing methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008—Fixation appliances for connecting prostheses to the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004—Rounded shapes, e.g. with rounded corners
    • A61F2230/0008—Rounded shapes, e.g. with rounded corners elliptical or oval
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017—Angular shapes
    • A61F2230/0019—Angular shapes rectangular
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028—Shapes in the form of latin or greek characters
    • A61F2230/005—Rosette-shaped, e.g. star-shaped
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063—Three-dimensional shapes
    • A61F2230/0069—Three-dimensional shapes cylindrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0037—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in height or in length
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0082—Additional features; Implant or prostheses properties not otherwise provided for specially designed for children, e.g. having means for adjusting to their growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels

Definitions

  • Valves exist in the body (e.g., in the heart and the systemic veins) to allow unidirectional blood flow.
  • a variety of congenital conditions, infectious diseases (e.g., rheumatic heart disease), endocarditis, and age-related impairments (e.g., senile stenosis) can necessitate implantation of an artificial valve.
  • an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent.
  • the plurality of leaflets form a plurality of coaptation regions between two adjacent leaflets.
  • the coaptation regions include extensions along a z-axis and adapted and are configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
  • the extensions can have a length along the z-axis between about 1 mm and about 10 mm.
  • the extensions can have a curved profile.
  • the curved profile can lie in an x-y plane.
  • the curved profile can be a variance in extension length along the z-axis.
  • the coaptation regions can have a substantially hyperbolic profile.
  • Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line.
  • the stent can be an expandable, cylindrical stent.
  • the leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
  • One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
  • Adjacent leaflets can be coupled to a wide post of the stent.
  • the wide post can include one or more windows.
  • the wide post can have a width between about 0.5 mm and about 3 mm.
  • the stent can include metal or plastic.
  • the metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
  • the leaflets can be formed from a first polymer.
  • the first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
  • the stent can be dip-coated in a second polymer.
  • the second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
  • the leaflets can be coupled to the second polymer.
  • the leaflets can be mechanically coupled to the second polymer.
  • the leaflets can be chemically coupled to the second polymer.
  • the leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
  • a leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent.
  • the leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
  • the stent can include one or more anchor points.
  • the anchor points can contain a radio-opaque material.
  • the valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
  • the valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency.
  • the valve can be adapted and configured for serial expansion as the subject ages.
  • an artificial, flexible valve including: a stent defining a wall and a plurality of leaflets extending from the wall of the stent. Each of the plurality of leaflets terminates in a commissure line.
  • the commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
  • the leaflets can further include extensions beyond the commissure lines along a z-axis.
  • the extensions can have a length along the z-axis between about 1 mm and about 10 mm.
  • the extensions can have a curved profile.
  • the curved profile can lie in an x-y plane.
  • the curved profile can be a variance in extension length along the z-axis.
  • Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line.
  • the stent can have an expandable, cylindrical stent.
  • the leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
  • One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
  • Adjacent leaflets can be coupled to a wide post of the stent.
  • the wide post can include one or more windows.
  • the wide post can have a width between about 0.5 mm and about 3 mm.
  • the stent can include metal or plastic.
  • the metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
  • the leaflets can be formed from a first polymer.
  • the first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
  • the stent can be dip-coated in a second polymer.
  • the second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
  • the leaflets can be coupled to the second polymer.
  • the leaflets can be mechanically coupled to the second polymer.
  • the leaflets can be chemically coupled to the second polymer.
  • the leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
  • a leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent.
  • the leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
  • the stent can include one or more anchor points.
  • the anchor points can contain a radio-opaque material.
  • the valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
  • the valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency.
  • the valve can be adapted and configured for serial expansion as the subject ages.
  • an artificial, flexible valve including: an expandable, cylindrical stent defining a wall and a plurality of leaflets extending from the wall of the stent. Adjacent leaflets can be coupled to a relatively wide post of the stent.
  • the leaflets can further include extensions beyond the commissure lines along a z-axis.
  • the extensions can have a length along the z-axis between about 1 mm and about 10 mm.
  • the extensions can have a curved profile.
  • the curved profile can lie in an x-y plane.
  • the curved profile can be a variance in extension length along the z-axis.
  • the coaptation regions can have a substantially hyperbolic profile.
  • Each of the plurality of leaflets can have a substantially elliptical leaflet-stent attachment line.
  • the leaflets can be reinforced with one or more selected from the group consisting of: reinforcing materials and directional fibers.
  • One or more selected from the group consisting of: coaptation regions and leaflet-stent attachment lines can be reinforced with one or more selected from the group consisting of: additional polymer thickness, reinforcing materials, and directional fibers.
  • the relatively wide post can include one or more windows.
  • the relatively wide post can have a width between about 0.5 mm and about 3 mm.
  • the stent can include metal or plastic.
  • the metal can be selected from the group consisting of: stainless steel, 316L stainless steel, cobalt-chromium alloys, and nickel-titanium alloys.
  • the leaflets can be formed from a first polymer.
  • the first polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
  • the stent can be dip-coated in a second polymer.
  • the second polymer can be selected from the group consisting of: polytetrafluoroethylene, polyethylene, polyurethane, silicone, and copolymers thereof.
  • the leaflets can be coupled to the second polymer.
  • the leaflets can be mechanically coupled to the second polymer.
  • the leaflets can be chemically coupled to the second polymer.
  • the leaflets can be coupled to the second polymer by one or more techniques selected from the group consisting of: gluing, chemical fusing, thermal fusing, sonic welding, stitching, and mechanical fastening.
  • a leaflet-stent attachment line for each of the plurality of leaflets can substantially approximate a frame of the stent.
  • the leaflet-stent attachment line can lie within about 3 mm of the frame of the stent.
  • the stent can include one or more anchor points.
  • the anchor points can contain a radio-opaque material.
  • the valve can be adapted and configured for replacement of one or more cardiac valves selected from the group consisting of: aortic, mitral, tricuspid, and pulmonary.
  • the valve can be adapted and configured for insertion in a subject's veins in order to treat venous insufficiency.
  • the valve can be adapted and configured for serial expansion as the subject ages.
  • the valve may not contain any animal-derived materials.
  • a mandrel including: a cylindrical profile and a plurality of recesses adapted and configured to define a plurality of leaflets forming a plurality of coaptation regions between two adjacent leaflets.
  • the coaptation regions can include extensions along a z-axis and be adapted and configured to form a releasable, but substantially complete seal when the leaflets are in a closed position.
  • the mandrel can include one more cutting guides located between the plurality of recesses.
  • the mandrel can include one or more heating elements.
  • a mandrel including: a cylindrical profile and a plurality of recesses adapted and configured to define a plurality of leaflets.
  • Each of the plurality of leaflets terminate in a commissure line.
  • the commissure lines deviate from a hyperbola formed in the x-y plane by at least one deviation selected from the group consisting of: a deviation in the z-direction and one or more curves relative to the hyperbola.
  • the mandrel can include one more cutting guides located between the plurality of recesses.
  • the mandrel can include one or more heating elements.
  • Another aspect of the invention provides a method for fabricating an artificial, flexible valve.
  • the method includes: dip coating a cylindrical mandrel having a plurality of recesses each approximating a profile of a leaflet and coupling the leaflets to an inner wall of a stent.
  • the method can further include dip coating the stent prior to coupling the leaflets to the inner wall of the stent.
  • the stent and the mandrel can have larger diameters than a target location for the valve.
  • the method can further include separating adjacent leaflets from each other.
  • FIGS. 1A and 1B provide perspective (in which fluid flows from the bottom of the stent toward the top of the stent) and top (in which fluid flows out of the page when the valve is open and flows down into the page to close the valve) views of a valve according to an embodiment of the invention
  • FIG. 2 depicts a stent according to an embodiment of the invention
  • FIGS. 3A-3F depict various stent geometries according to embodiments of the invention.
  • FIG. 4 depicts various vertical post geometries according to embodiments of the invention.
  • FIGS. 5A-5D depict the positioning of a leaflet joint adjacent to a window of a vertical post according to an embodiment of the invention
  • FIG. 6 depicts a stent prior to expansion, dip coating, and leaflet installation according to an embodiment of the invention
  • FIG. 7 depicts a stent including one or more anchor points according to an embodiment of the invention.
  • FIG. 8 depicts the engagement of a stent with a holder for dipping and rotation according to an embodiment of the invention
  • FIGS. 9A-9E depict a mandrel according to an embodiment of the invention.
  • FIG. 9F depicts the positioning of a hyperbolic commissure line relative to defined asymptotes according to embodiments of the invention.
  • FIG. 10A depicts a comparison of elliptical vs. parabolic geometries leaflet valley lines according to embodiments of the invention.
  • FIGS. 10B and 10C depict a comparison of elliptical vs. parabolic leaflet stent attachment lines according to embodiments of the invention.
  • FIGS. 11A-11D depict mandrels for forming coaptation regions of varying height according to embodiments of the invention.
  • FIGS. 12A-12D depict mandrels for forming coaptation regions of varying radial length according to embodiments of the invention
  • FIGS. 12E-12H depict mandrels for forming commissure lines having variable depths along the z-axis according to embodiments of the invention
  • FIGS. 12I-12K depict mandrels for forming coaptation regions having curved profiles in an x-y plane, resulting in increased coaptation length, according to embodiments of the invention
  • FIGS. 12L-12N depict mandrels for forming commissure lines having curved profiles in an x-y plane, resulting in increased coaptation length, according to embodiments of the invention
  • FIG. 13A depicts a mandrel according to an embodiment of the invention
  • FIGS. 13B and 13C depict the positioning of reinforcing zones on a mandrel according to an embodiment of the invention
  • FIGS. 14A-14C depict various top profiles according to an embodiment of the invention.
  • FIGS. 15A and 15B depict the fabrication of valves according to embodiments of the invention.
  • FIG. 16 depict the fabrication of valves according to an embodiment of the invention.
  • FIGS. 17A and 17B depict the compression of a valve after assembly in order to bring leaflets into contact with each other according to embodiments of the invention
  • FIG. 17C is a high-speed photograph of a closed valve under pressure according to embodiments of the invention.
  • FIG. 18 depicts a method of implanting a valve according to embodiments of the invention.
  • FIG. 19 depicts a method of expanding an implanted valve according to embodiments of the invention.
  • the term “about” is understood as within a range of normal tolerance in the art, for example within 2 standard deviations of the mean. “About” can be understood as within 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05%, or 0.01% of the stated value. Unless otherwise clear from context, all numerical values provided herein are modified by the term about.
  • Ranges provided herein are understood to be shorthand for all of the values within the range.
  • a range of 1 to 50 is understood to include any number, combination of numbers, or sub-range from the group consisting 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 (as well as fractions thereof unless the context clearly dictates otherwise).
  • aspects of the invention provide a novel platform that allows development of polymeric valves of any size and shape.
  • aspects of the invention can be applied to valves designed for surgical implantation (e.g., through a sternotomy or thoracotomy) or valves designed for percutaneous, transcatheter implantation. Additionally, embodiments of the invention allow for possible percutaneous replacement of a dysfunctional valve, whether in adults or in small children. In addition, if implanted in a child, embodiments of the invention allow the valve to be serially expanded to accompany the child's growth.
  • Heart valves are currently replaced using tissue valves (homograft or xenograft) or mechanical metal valves, each having their shortcomings. Homograft valves are in short supply, particularly in sizes suitable for use in children, and biologic tissue-based valves (whether bovine, porcine, or homograft) tend to induce an immunologic reaction which leads to failure of these valves. Mechanical valves generally require anticoagulation, and are almost never used in the pulmonary position due to an increased risk of thrombosis.
  • aspects of the invention can be used for venous valve replacement in patients having venous disease such as chronic venous insufficiency (leading to leg swelling). Because the polymer leaflets can be made extremely thin, the valves can even open under extremely low venous pressure gradients.
  • valve 100 provides an artificial, flexible valve 100 .
  • the valve includes an expandable, cylindrical stent 102 defining a wall 104 .
  • Valve 100 further includes a plurality of leaflets 106 a - 106 c .
  • Wall 104 can be formed by dip coating stent 102 in a polymer as further described herein.
  • Leaflets 106 can be coupled to wall 104 along seams 108 using a variety of approaches (e.g., glue) as discussed further herein.
  • Stent 102 can include one or more vertical posts 110 , 112 , which can be relatively narrow posts 110 or relatively wide posts 112 .
  • leaflet joints between adjacent leaflets 106 are positioned on or close to a vertical post 110 , 112 of the stent 102 .
  • valve 100 will now be described in the context of its components and methods of fabrication.
  • stent 102 can be a metallic stent having plurality of wires, strips, and the like 202 defining a plurality of cells 204 , 206 of various sizes.
  • Stent 102 can be fabricated from a variety of malleable materials such as stainless steel, 316L stainless steel, cobalt-chromium alloys, nickel-titanium alloys (colloquially known as “nitinol”), and the like.
  • Stent 102 can also be formed from various non-metallic materials such as plastics such as polyethylene, polyurethane, polytetrafluoroethylene (PTFE), silicone, poly(propylene) (PP), polyethylene terephthalate (PET), and the like.
  • plastics such as polyethylene, polyurethane, polytetrafluoroethylene (PTFE), silicone, poly(propylene) (PP), polyethylene terephthalate (PET), and the like.
  • Stent 102 can be completely enveloped by a polymer dip coating.
  • Stent 102 and/or wall 104 can also be fabricated from a biocompatible material.
  • the stent 102 can be manufactured by laser cutting or wire forming. To increase bonding strength between metal and polymer, roughness of stent surface can be controlled. Some or all open cells 204 , 206 of the stent can be covered as the bare 102 stent is dipped into the polymer solution.
  • FIG. 6 depicts a stent 102 prior to expansion, dip coating, and leaflet installation.
  • Stents 102 typically have a diameter of between about 2 mm and 6 mm prior to expansion and can be expanded to between about 5 mm and about 30 mm for implantation into a subject.
  • the components of stent 102 can have a variety of dimensions that can be selected to achieve a desired flexibility, rigidity, resilience, and the like.
  • the thickness and width of components of the stent 102 can be between about 0.1 mm and about 2 mm.
  • stent 102 can include one or more vertical posts 110 a - 110 c to enhance bonding with leaflets 106 .
  • Stent 102 can include a plurality of vertical posts 110 that can serve a variety of functions. Some vertical posts 110 can include additional structure and are referred to herein as wide posts 112 . Wide posts 112 are preferably located at leaflet joints where two leaflets 106 meet. For example, in a valve 100 having a three leaflets 106 , wide posts 112 can be positioned at 120° intervals within cylindrical stent 102 .
  • Wide posts 112 provide mechanical support to leaflets and prevent or substantially limit inward deformation of wall 104 due to tensile forces applied to leaflets 106 transferred to wall 104 . Without being bound by theory, it is believed that the wide posts 112 provide increased strength and resiliency due to formation of polymer wall 104 through windows 206 and around wide posts 112 , thus providing cohesive holding of the polymer to itself around the stent 102 instead of relying solely on adhesive bonding of the polymer wall 104 to the stent 102 .
  • window 208 can have a width of between about 0.5 mm and about 3 mm (e.g., about 1 mm) and a height of between about 1 mm and about 10 mm (e.g., about 5 mm).
  • FIGS. 3A-3F A variety of additional wide post geometries are depicts in FIGS. 3A-3F .
  • the wide posts have a solid architecture without any windows.
  • the wide posts have a substantially rectangular architecture defining a single, long window as in FIGS. 1A, 1B, and 2 .
  • the wide posts define a plurality of coaxial substantially rectangular windows.
  • the wide posts define a plurality of coaxial, substantially parallel windows.
  • FIG. 3E the wide posts define a plurality of coaxial, substantially rectangular windows in a 2 ⁇ 3 arrangement.
  • the wide posts include a plurality of circular windows.
  • any geometry can be utilized including windows having a profile approximating a triangle, a square, an n-gon (e.g., a hexagon, an octagon, and the like), and the like.
  • FIGS. 5A-5D the positioning of a leaflet joint 502 (formed, e.g., on mandrel 900 as discussed herein) adjacent to window 206 of wide post 112 is depicted.
  • the polymer dip-coated wall 104 is completely transparent for ease and clarity in viewing, but can be transparent, translucent, or opaque.
  • FIG. 5B-5D further depict how a geometry of the stent 102 can be selected to substantially approximate the leaflet-stent attachment seam 108 discussed herein in order to provide added mechanical support and resiliency.
  • stent 102 can include one or more anchor points 702 .
  • Anchor points 702 advantageously facilitate holding, dipping, and rotation of the stent 102 during the dip coating process without interfering with the dip coating of the remainder of the stent architecture. Accordingly, the entire stent 102 can be dip coated in a single dipping, although multiple dippings can be utilized to control coating density, thickness, and the like.
  • Anchor points 702 can also receive one or more radio-opaque materials such as platinum to aid in placement and visualization of the valve.
  • stent 102 can be engaged with a holder 802 (e.g., by posts 804 ) for dipping and rotation.
  • a holder 802 e.g., by posts 804
  • the polymer e.g., polymer that is wet on the stent 102
  • the stent can be positioned horizontally and rotated axially.
  • Leaflets 106 can be formed using a variety of techniques including dip coating, 3D-printing (also known as additive manufacturing), molding, and the like.
  • leaflets 106 can be fabricated by dip coating a mandrel 900 with a polymer.
  • the mandrel 900 can be made with a solid such as a metal (e.g., stainless steel, titanium, aluminum, and the like), a plastic (e.g., polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, polyoxymethylene, and the like), and the like. Since the coated polymer leaflets 106 will be removed from the mandrel 900 after the polymer dries, roughness of mandrel surface can be controlled using known machining and other manufacturing techniques.
  • the mandrel 900 can be made from a cylinder.
  • the diameter of the mandrel 900 is a slightly (e.g., between about 0.05 and about 0.4 mm) smaller than inner diameter of stent 102 after expansion.
  • the mandrel 900 for the leaflets 106 can have novel features, including edges representing the leaflet attachment points that are mathematically defined and leaflet tips that are extended in order to increase the coaptation length of the leaflets.
  • the mandrel 900 can be dimensioned to produce leaflets 106 having different regional thickness and supplementary materials such as directional fibers or reinforcing particles inserted between layers or mixed into the polymer solution in order to increase durability. For example, polymer interaction with particles on the nanoscale or microscale can greatly improve the physical properties or tear resistance of the polymer leaflets 106 .
  • Mandrel 900 can be designed to have a complementary geometry to the desired leaflet shape and permits easier viewing of leaflet geometry. Although mandrel 900 is utilized to describe the geometry of the leaflet 106 , it should be recognized that the upstream surface of the resulting leaflets will have this geometry when formed by dip coating and that the complementary geometry of the leaflet(s) 106 can be produced using techniques other than dip coating.
  • Mandrel 900 is preferably cylindrical and can have an outer profile substantially approximating an inner profile of stent 102 .
  • Mandrel 900 can define a plurality of pockets 902 that each define a leaflet 106 as it hangs from wall 104 via attachment line 108 .
  • Each leaflet 106 terminates in a commissure line 904 often, but not necessarily lying in a plane at the point where the elliptical or parabolic curve ends and where the leaflet often contacts the other leaflets.
  • a substantially vertical coaptation region 906 can extend beyond the commissure line 904 to an extended commissure line 912 for improved sealing as will be discussed herein.
  • mandrel can be cast, machined, printed, or otherwise fabricated so that pockets 902 have a desired geometry.
  • the commissure line 904 (and optionally the coaptation region 906 and extended commissure line 912 ) has a substantially hyperbolic profile when viewed in the x-y plane.
  • leaflet-stent attachment line 108 and/or a leaflet valley line 908 (formed by taking a cross-section in a z plane) can have substantially elliptical profiles.
  • elliptical profiles better promote a secure pocket shape and the closure of the leaflet-stent attachment line 108 to the contour of the cylindrical mandrel 900 .
  • a comparison of elliptical vs. parabolic leaflet valley lines is provided in FIG. 10A .
  • a comparison of elliptical vs. parabolic leaflet-stent attachment lines is provided in FIGS. 10B and 10C .
  • mandrel 900 can define a gap 910 between adjacent leaflets.
  • leaflets 106 with a hyperbolic profile can produce smaller gaps than leaflets with parabolic profiles.
  • gaps 910 can be less than 1 mm or between about 0.1 mm and about 1 mm (e.g., between about 0.1 mm and about 0.2 mm, between about 0.2 mm and about 0.3 mm, between about 0.3 mm and about 0.4 mm, between about 0.4 mm and about 0.5 mm, between about 0.5 mm and about 0.6 mm, between about 0.6 mm and about 0.7 mm, between about 0.7 mm and about 0.8 mm, about 0.8 mm and about 0.9 mm, about 0.9 mm and about 1 mm, and the like).
  • the length of hyperbolic commissure line 904 is about twice the radius of the stent or mandrel.
  • the positioning of a hyperbolic commissure line 904 relative to defined asymptotes is depicted in FIG. 9F .
  • coaptation region can have minimal height in the z-axis so as to consist only of the commissure line 904 .
  • coaptation region 906 can have a vertical extension in the z-axis to an extended commissure line 912 as depicted in FIGS. 11B-11D .
  • the height of the coaptation region 906 can be selected to reduce the amount of regurgitation, while still allowing the valve to open.
  • the coaptation region 906 can have a height between about 1 mm and about 10 mm (e.g., about 3 mm).
  • 11B-11D depict extensions of coaptation region 904 that extend solely in the z-axis, the same effect can be achieved using a smooth leaflet-stent attachment line that extends in the z-axis so that the adjacent leaflet-stent attachment lines (and/or the regions of leaflets hanging therebetween) approach and/or contact each other to form an extended coaptation region.
  • the zone of coaptation is affected by the pressure placed upon the closed valve 100 .
  • Proper coaptation also allows the leaflets 106 to support each other, so there is less stress placed on any individual leaflet 106 .
  • Another benefit of enhancing height of the coaptation zone is that this allows the valve 100 to be re-dilated to a larger diameter late after implantation (such as to accommodate growth of a pediatric patient), while still maintaining competence of the valve 100 .
  • Options for enhancing the height of the coaptation zone include creating excess length of the leaflet free edges, so that the free edge length is greater than twice the radius of the stent or mandrel depicted in FIG. 9E . Lengthening of the leaflet free edges can be accomplished by curved edges in the x-y plane, or in the z-axis, or in all 3 axes.
  • coaptation regions 906 can have varying heights in the z-axis between the commissure line 904 and extended commissure line 912 .
  • the height of coaptation region 906 can increase toward the outside of the mandrel as depicted in FIG. 12B .
  • the height of the coaptation region 906 can dip to form a trough between the outside and the center of the mandrel 900 as depicted in FIG. 12C .
  • the commissure lines 904 , coaptation regions 906 and/or extended commissure lines 912 can have curved profiles in an x-y plane (as opposed to a substantially hyperbolic profile) in order to increase the length of the commissure line 904 , coaptation region 906 , and/or extended commissure line 912 .
  • the mandrel 900 can be thicker between the perimeter and the center as depicted in FIG. 12I to produce one or more scallops.
  • the mandrel 900 can have either a single curve or multiple curves.
  • the thickness of the leaflets 106 can be controlled regionally. Because the most common failure points are at the outer edges of the leaflets 106 (such as commissure line 904 or extended commissure line 912 and leaflet-stent attachment line 108 ), increased thickness at outer areas of the leaflets 106 can improve the strength and durability. Also, if local areas are expected to have concentrated stress, the areas can be locally reinforced (e.g., made thicker than other areas). The thickness can be smoothly increased.
  • the width of thickened area along leaflet-stent attachment line 108 can be large enough to cover the glued area for bonding the leaflets 106 and the covered stent 102 .
  • the thickness of thickened areas of the leaflets is between about 0.1 mm and about 1 mm.
  • the thickness of the leaflets is between about 0.01 mm and about 0.2 mm.
  • Different reinforcing materials such as strips, fibers and particles can be placed between the layers, or directly mixed into the polymer solution.
  • the inserted material(s) can prevent tearing and reduce propagation of the tear if it occurs.
  • the materials can have directional properties and can be layered onto, or embedded into, the leaflets in an optimal direction to prevent or limit tears.
  • a reinforcing zone 1302 can be formed on the mandrel 900 prior either by removing mandrel material to allow for additional thickness in certain (e.g., outer) regions of leaflets 106 or by introducing one or more reinforcing fibers prior to, during, or after dip coating.
  • Suitable reinforcing materials include fibers (e.g., polymers, nanotubules, aramids, para-aramids, and the like), wires, and the like. Transitions between reinforced and non-reinforced areas can be smooth in order to minimize any turbulence in the implanted valve 100 .
  • the coated polymer After dipping the mandrel 900 into the polymer solution, the coated polymer dries in order to form the leaflet(s) 106 . Because the formed leaflets 106 are connected, they need to be separated from each other. These can be cut by a sharp cutter (e.g., a knife, a scalpel, a razor blade, a utility knife, and the like), a heated iron, a laser, a rotary tool, and the like.
  • a guide on the top surface of the mandrel for cutting provides a clear, easy, and safe cutting path.
  • the guide can be grooved/concave or convex.
  • the commissure edges of the mandrel can be sharp like a blade to facilitate leaflet separation and to improve on the quality of the cut edges.
  • the gap portion 910 of the mandrel can have various top profiles to facilitate sealing of the leaflets and/or separation of the leaflets prior to removal from mandrel 900 .
  • the gap portion 910 can have a grooved profile as depicted in FIG. 14A , a concave profile as depicted in FIG. 14B , or an angled profile as depicted in FIG. 14C .
  • a heating element e.g., an Ohmic or resistive heating element such as a wire
  • the stent-mounted valve 100 can be implanted with smaller diameter than its manufactured diameter for reducing leakage and improving durability.
  • FIGS. 15A, 15B, and 16 a method for fabricating a valve is depicted.
  • a bare stent 102 and a bare mandrel 900 are provided.
  • the stent 102 can be first coated with a polymer such as PEEK or other metal surface modifier prior to further dip coating of the stent 102 in another polymer in order to improve adhesion of the leaflet polymer 106 to the metal stent 102 .
  • a polymer such as PEEK or other metal surface modifier
  • the bare mandrel 900 can optionally be coated with a release agent to promote separation of the polymer leaflets from the mandrel 900 .
  • Both the bare stent 102 and the mandrel 900 are dip coated separately in a polymer, which may be the same or different for the bare stent 102 and the mandrel 900 .
  • the leaflets 106 formed on the mandrel 900 can be removed prior to introduction to the coated stent.
  • the coated mandrel 900 can be introduced into the coated stent, the leaflets 106 can be bonded to the coated stent, and the mandrel 900 can be then be removed to leave the assembled valve 100 .
  • Leaflets 106 can be bonded to the dip-coated stent using a variety of techniques including gluing, chemical fusing (i.e., dissolving the polymers) thermal fusing, sonic welding, stitching, mechanical fastening, and the like.
  • gluing i.e., dissolving the polymers
  • thermal fusing i.e., thermal fusing
  • sonic welding i.e., sonic welding
  • stitching i.e., stitching, mechanical fastening, and the like.
  • the entire valve could be formed in a single dip coating (or series of dip coatings) through use of production-grade manufacturing techniques and other optimizations.
  • dipcoating was successfully used to fabricate prototypes of the valves described herein, any other manufacturing technique capable of producing flexible leaflets can be utilized.
  • Exemplary techniques include injection molding and additive manufacturing or 3D printing.
  • stent 102 and leaflets 106 can be fabricated based on a diameter that is slightly larger than the placement location as depicted in FIG. 17A .
  • the leaflets 106 When deployed to a location having a smaller diameter than the manufactured diameter, the leaflets 106 will be held in tight contact with each other as seen in FIG. 17B to form a tight seal.
  • the deployed diameter In order to form a press fit with the vessel wall, the deployed diameter will be greater than the vessel diameter, but less than the manufactured diameter.
  • the coaptation regions of leaflets 106 have a substantially hyperbolic profile both at the manufactured diameter and the deployed diameter.
  • FIG. 17C a high-speed photograph of a closed valve under pressure during in vitro testing in a hemodynamic pulse duplicator is provided.
  • the leaflets 106 can be formed from the same or different polymer with which the stent 102 is coated to form wall 104 .
  • the leaflets 106 can be formed from polymers such as polyethylene, polyurethane, silicone, and the like.
  • Wall 104 can be formed from polyethylene, polyurethane, silicone, and the like.
  • Supplementary materials such as directional fibers can mixed into the polymer solution or applied to the leaflets between coatings in order to increase durability
  • the selected polymer can be dissolved by a solvent such as tetrahydrofuran or dimethylacetamide.
  • the thickness of the coated polymer can be controlled as a function of the density of the polymer solution and total number of dippings. When the polymer becomes dry after dipping, the coated stent and mandrel can be placed horizontally and axially rotated in order to produce a constant thickness and prevent the polymer from dripping.
  • the valve to be implanted can be a valve 100 as described herein.
  • step S 1802 the valve is placed over an expander and within a sheath.
  • Various surgical expanders and access devices exist in the cardiac surgery field.
  • a balloon catheter could be introduced into a patient's femoral artery and guided to the location of the implanted valve (e.g., within the patient's heart or systemic veins).
  • step S 1804 the sheath (containing the valve and the expander) is introduced into a vessel of the subject.
  • step S 1806 the valve and the expander are advanced from the sheath and positioned in the desired location.
  • step S 1808 the desired positioning can be verified using various imaging techniques such as fiber optics, ultrasound, X-ray, and the like.
  • step S 1810 the expander is actuated within the valve to expand the valve to form a press fit against the vessel in which the valve is implanted.
  • a balloon catheter can be expanded by introducing gas or a liquid into the balloon.
  • step S 1812 the desired positioning and expansion can be verified using various imaging techniques such as fiber optics, ultrasound, X-ray, and the like.
  • step S 1814 the expander and sheath can be retracted according to standard surgical techniques.
  • the implanted valve can be a valve 100 as described herein.
  • step S 1902 an expander is introduced into the implanted valve.
  • step S 1904 the expander is actuated within the implanted valve to increase the diameter of the implanted valve.
  • step S 1906 the desired expansion can be verified using various imaging techniques.
  • step S 1908 the expander can be retracted according to standard surgical techniques.
  • embodiments of the invention are described and depicted in the context of percutaneous, transcatheter valves having expandable, cylindrical stents
  • embodiments of the invention described herein can be applied to surgically-implanted valves that generally include anchors having fixed-diameter anchors supporting a plurality of leaflets (e.g., the CARPENTIER-EDWARDSTM series of valves available from Edwards Lifesciences Corporation of Irvine, Calif.).
  • the anchor replaces the expandable, cylindrical stents described herein.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
US15/308,667 2014-05-07 2015-05-06 Artificial, flexible valves and methods of fabricating and serially expanding the same Abandoned US20170189175A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/308,667 US20170189175A1 (en) 2014-05-07 2015-05-06 Artificial, flexible valves and methods of fabricating and serially expanding the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461989820P 2014-05-07 2014-05-07
PCT/US2015/029442 WO2015171743A2 (fr) 2014-05-07 2015-05-06 Valves flexibles artificielles et procédés de fabrication et expansion en série de celles-ci
US15/308,667 US20170189175A1 (en) 2014-05-07 2015-05-06 Artificial, flexible valves and methods of fabricating and serially expanding the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/029442 A-371-Of-International WO2015171743A2 (fr) 2014-05-07 2015-05-06 Valves flexibles artificielles et procédés de fabrication et expansion en série de celles-ci

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/563,229 Continuation US20200000581A1 (en) 2014-05-07 2019-09-06 Artificial, flexible valves and methods of fabricating and serially expanding the same

Publications (1)

Publication Number Publication Date
US20170189175A1 true US20170189175A1 (en) 2017-07-06

Family

ID=54393140

Family Applications (5)

Application Number Title Priority Date Filing Date
US15/308,667 Abandoned US20170189175A1 (en) 2014-05-07 2015-05-06 Artificial, flexible valves and methods of fabricating and serially expanding the same
US16/563,229 Abandoned US20200000581A1 (en) 2014-05-07 2019-09-06 Artificial, flexible valves and methods of fabricating and serially expanding the same
US17/473,653 Active US11464632B2 (en) 2014-05-07 2021-09-13 Transcatheter and serially-expandable artificial heart valve
US17/478,665 Active 2035-07-06 US11571300B2 (en) 2014-05-07 2021-09-17 Serially expanding an artificial heart valve within a pediatric patient
US17/982,232 Pending US20230135271A1 (en) 2014-05-07 2022-11-07 Serially expanding an artificial heart valve within a pediatric patient

Family Applications After (4)

Application Number Title Priority Date Filing Date
US16/563,229 Abandoned US20200000581A1 (en) 2014-05-07 2019-09-06 Artificial, flexible valves and methods of fabricating and serially expanding the same
US17/473,653 Active US11464632B2 (en) 2014-05-07 2021-09-13 Transcatheter and serially-expandable artificial heart valve
US17/478,665 Active 2035-07-06 US11571300B2 (en) 2014-05-07 2021-09-17 Serially expanding an artificial heart valve within a pediatric patient
US17/982,232 Pending US20230135271A1 (en) 2014-05-07 2022-11-07 Serially expanding an artificial heart valve within a pediatric patient

Country Status (4)

Country Link
US (5) US20170189175A1 (fr)
EP (1) EP3139865B1 (fr)
CA (1) CA2948179C (fr)
WO (1) WO2015171743A2 (fr)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110353858A (zh) * 2018-04-09 2019-10-22 倍芮医疗器械（上海）有限公司 用于负载瓣膜的支架以及静脉瓣置换装置
US20190343625A1 (en) * 2017-12-11 2019-11-14 Foldax, Inc. Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves
WO2020191386A1 (fr) * 2019-03-21 2020-09-24 The Trustees Of Columbia University In The City Of New York Prothèse transcathéter à tube à valve pour stent polymère biostable et dilatable
CN111818876A (zh) * 2017-11-16 2020-10-23 儿童医学中心公司 几何适应性心脏瓣膜置换装置
US11039919B2 (en) 2017-10-31 2021-06-22 W. L. Gore & Associates, Inc. Valved conduit
US20210338422A1 (en) * 2017-09-27 2021-11-04 W. L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
WO2022066961A1 (fr) * 2020-09-23 2022-03-31 ReValve Solutions Inc. Dispositifs, systèmes et procédés pour un adaptateur de valve cardiaque implantable
US11351058B2 (en) 2017-03-17 2022-06-07 W. L. Gore & Associates, Inc. Glaucoma treatment systems and methods
US11464632B2 (en) * 2014-05-07 2022-10-11 Baylor College Of Medicine Transcatheter and serially-expandable artificial heart valve
US11547557B2 (en) 2018-12-13 2023-01-10 Abbott Laboratories Stabilized fabric material for medical devices
USD977642S1 (en) 2018-10-29 2023-02-07 W. L. Gore & Associates, Inc. Pulmonary valve conduit
US11617644B2 (en) 2014-10-13 2023-04-04 W. L. Gore & Associates, Inc. Prosthetic valved conduit
WO2023060330A1 (fr) * 2021-10-15 2023-04-20 Angel Maluf Miguel Prothèse de stent-valve expansible recouverte de polyuréthane avec formation de cuspides anatomiques pour implantation par cathéter en position pulmonaire chez de patients pédiatriques et adultes, et procédé d'obtention de la prothèse de stent-valve expansible
WO2023095033A1 (fr) * 2021-11-23 2023-06-01 Medtronic, Inc. Conception de feuillet pour une prothèse de valve cardiaque
US11678983B2 (en) 2018-12-12 2023-06-20 W. L. Gore & Associates, Inc. Implantable component with socket
CN116549736A (zh) * 2023-05-29 2023-08-08 哈尔滨工业大学 生物医用织物复合材料薄膜的制备方法
JP2023545268A (ja) * 2020-10-06 2023-10-27 エドワーズ ライフサイエンシーズ コーポレイション 人工弁用の保護カバー
EP4351477A1 (fr) * 2021-06-07 2024-04-17 Edwards Lifesciences Corporation Feuillets et séparateurs de feuillets pour valves prothétiques
US11969342B2 (en) 2022-08-03 2024-04-30 The Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
EP4378423A1 (fr) * 2022-10-04 2024-06-05 Medtronic Vascular Inc. Prothèse valvulaire à valve prothétique durable
US20240382326A1 (en) * 2019-02-28 2024-11-21 Renata Medical, Inc. Growth Stent and Valve for Congenital Narrowings
US20240415642A1 (en) * 2020-04-24 2024-12-19 ReValve Solutions Inc. Devices, systems, and methods for a valve replacement
US12239573B2 (en) 2018-08-29 2025-03-04 W. L. Gore & Associates, Inc. Drug therapy delivery systems and methods
US12279954B2 (en) 2017-10-31 2025-04-22 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
US12396845B2 (en) * 2018-12-13 2025-08-26 Abbott Laboratories Fabric material for medical devices

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6010545B2 (ja) 2010-12-23 2016-10-19 トゥエルヴ， インコーポレイテッド 僧帽弁の修復および置換のためのシステム
CA2840084C (fr) 2011-06-21 2019-11-05 Foundry Newco Xii, Inc. Dispositifs de valvule cardiaque prosthetiques et systemes et procedes associes
AU2012325813A1 (en) 2011-10-19 2014-04-03 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
CA2848334C (fr) 2011-10-19 2020-10-20 Twelve, Inc. Dispositifs, systemes et procedes de remplacement de valvule cardiaque
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
US10321986B2 (en) 2012-12-19 2019-06-18 W. L. Gore & Associates, Inc. Multi-frame prosthetic heart valve
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9737398B2 (en) 2012-12-19 2017-08-22 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
US10966820B2 (en) 2012-12-19 2021-04-06 W. L. Gore & Associates, Inc. Geometric control of bending character in prosthetic heart valve leaflets
US10039638B2 (en) 2012-12-19 2018-08-07 W. L. Gore & Associates, Inc. Geometric prosthetic heart valves
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
JP6545665B2 (ja) 2013-05-20 2019-07-17 トゥエルヴ， インコーポレイテッド 埋込可能な心臓弁デバイス、僧帽弁修復デバイス、および関連するシステムおよび方法
JP6690834B2 (ja) 2014-05-06 2020-04-28 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 人工弁および人工弁の製造方法
JP6445683B2 (ja) 2014-08-18 2018-12-26 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティドＷ．Ｌ． Ｇｏｒｅ ＆ Ａｓｓｏｃｉａｔｅｓ， Ｉｎｃｏｒｐｏｒａｔｅｄ 人工弁のための一体型縫合カフを有するフレーム
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
CN111658234B (zh) 2015-08-21 2023-03-10 托尔福公司 可植入心脏瓣膜装置、二尖瓣修复装置以及相关系统和方法
CN116172753A (zh) 2016-04-29 2023-05-30 美敦力瓦斯科尔勒公司 具有带系绳的锚定件的假体心脏瓣膜设备以及相关联的系统和方法
GB201616777D0 (en) 2016-10-03 2016-11-16 Univ Southampton A frame for an implantable medical device and a method of manufacturing a frame for an implantable medical device
CN108430394A (zh) * 2016-12-15 2018-08-21 美利奴生命科学有限公司 人造瓣膜
CN108261255B (zh) * 2016-12-30 2020-12-25 先健科技(深圳)有限公司 人工心脏瓣膜装置及其瓣叶和支架主体
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
AU2018334191B2 (en) 2017-09-12 2021-04-08 Edwards Lifesciences Corporation Leaflet frame attachment for prosthetic valves
AU2018342222B2 (en) 2017-09-27 2021-05-20 Edwards Lifesciences Corporation Prosthetic valve with expandable frame and associated systems and methods
US11090153B2 (en) 2017-10-13 2021-08-17 W. L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
EP3703616A1 (fr) 2017-10-31 2020-09-09 W. L. Gore & Associates, Inc. Valve médicale et feuillet favorisant l'interposition tissulaire
CA3187189A1 (fr) 2017-10-31 2019-05-09 W.L. Gore & Associates, Inc. Valve cardiaque prothetique
US11154397B2 (en) 2017-10-31 2021-10-26 W. L. Gore & Associates, Inc. Jacket for surgical heart valve
USD926322S1 (en) 2018-11-07 2021-07-27 W. L. Gore & Associates, Inc. Heart valve cover
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
US12447014B2 (en) 2019-04-12 2025-10-21 Edwards Lifesciences Corporation Valve with multi-part frame and associated resilient bridging features
EP4629933A1 (fr) 2022-12-09 2025-10-15 Renata Medical, Inc. Dispositifs de croissance par cathéter et méthodes s'appliquant aux interventions de norwood, glenn et fontan

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086612A (en) * 1996-06-24 2000-07-11 Adiam Medizintechnik Gmbh & Co. Kg Mitral valve prosthesis
US6171335B1 (en) * 1997-01-24 2001-01-09 Aortech Europe Limited Heart valve prosthesis
US20010007956A1 (en) * 1996-12-31 2001-07-12 Brice Letac Valve prosthesis for implantation in body channels
US20080200980A1 (en) * 2006-10-19 2008-08-21 Kevin Robin Profile reduction of valve implant
US20100145435A1 (en) * 2008-02-21 2010-06-10 Valerian Voinov Implantable prosthetic valve stent
US20120053676A1 (en) * 2009-05-07 2012-03-01 Ku David N Implantable Prosthetic Vascular Valves
US20120277856A1 (en) * 2001-10-11 2012-11-01 Edwards Lifesciences Pvt, Inc. Implantable prosthetic valve
US20140316516A1 (en) * 2012-01-04 2014-10-23 Tendyne Holdings, Inc. Multi-component cuff designs for transcatheter mitral valve replacement subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly

Family Cites Families (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655306A (en) 1970-01-19 1972-04-11 Donald Nixon Ross Apparatus for molding heart valves
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3744060A (en) 1971-06-10 1973-07-10 F Bellhouse Prosthetic cardiac valve
US4056854A (en) 1976-09-28 1977-11-08 The United States Of America As Represented By The Department Of Health, Education And Welfare Aortic heart valve catheter
NL8500538A (nl) 1985-02-26 1986-09-16 Stichting Tech Wetenschapp Hartklepprothese, werkwijze voor het vervaardigen van een hartklepprothese en daarbij toegepaste mal.
DE3541478A1 (de) 1985-11-23 1987-05-27 Beiersdorf Ag Herzklappenprothese und verfahren zu deren herstellung
DK124690D0 (da) 1990-05-18 1990-05-18 Henning Rud Andersen Klapprotes til implantering i kroppen for erstatning af naturlig klap samt kateter til brug ved implantering af en saadan klapprotese
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5163955A (en) * 1991-01-24 1992-11-17 Autogenics Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment
JP2002509448A (ja) 1992-01-27 2002-03-26 メドトロニック インコーポレーテッド 輪状形成及び縫合リング
GB9206449D0 (en) 1992-03-25 1992-05-06 Univ Leeds Artificial heart valve
US5713950A (en) 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5509930A (en) 1993-12-17 1996-04-23 Autogenics Stentless heart valve
US5562729A (en) 1994-11-01 1996-10-08 Biocontrol Technology, Inc. Heart valve
DE19546692C2 (de) 1995-12-14 2002-11-07 Hans-Reiner Figulla Selbstexpandierende Herzklappenprothese zur Implantation im menschlichen Körper über ein Kathetersystem
US5855601A (en) 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
DE19624948A1 (de) 1996-06-24 1998-01-02 Adiam Medizintechnik Gmbh & Co Prothetische Herzklappe
US6764509B2 (en) 1996-09-06 2004-07-20 Carbomedics Inc. Prosthetic heart valve with surface modification
US6206911B1 (en) 1996-12-19 2001-03-27 Simcha Milo Stent combination
US5957949A (en) 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US5855597A (en) 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6117169A (en) 1998-06-24 2000-09-12 Sulzer Carbomedics Inc. Living hinge attachment of leaflet to a valve body
US6736845B2 (en) 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US8382822B2 (en) 1999-06-02 2013-02-26 Cook Medical Technologies Llc Implantable vascular device
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
US6299637B1 (en) 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US7195641B2 (en) 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
GB9928905D0 (en) * 1999-12-08 2000-02-02 Aortech Europ Ltd Prosthesis
US20030097175A1 (en) * 1999-12-08 2003-05-22 O'connor Bernard Heart valve prosthesis and method of manufacture
GB0114345D0 (en) 2001-06-13 2001-08-08 Aortech Europ Ltd Heart valve prosthesis and method of manufacture
WO2001054624A1 (fr) 2000-01-27 2001-08-02 3F Therapeutics, Inc. Prothese de valvule cardiaque
US6454799B1 (en) * 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US7510572B2 (en) 2000-09-12 2009-03-31 Shlomo Gabbay Implantation system for delivery of a heart valve prosthesis
US6482228B1 (en) 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement
US6953332B1 (en) 2000-11-28 2005-10-11 St. Jude Medical, Inc. Mandrel for use in forming valved prostheses having polymer leaflets by dip coating
US6454798B1 (en) 2000-12-21 2002-09-24 Sulzer Carbomedics Inc. Polymer heart valve with helical coaption surface
US6596024B2 (en) 2000-12-21 2003-07-22 Carbomedics Inc. Polymeric heart valve fabricated from polyurethane/polysiliconeurethane blends
US6916338B2 (en) 2001-03-16 2005-07-12 Mayo Foundation For Medical Education And Research Synthetic leaflets for heart valve repair or replacement
US7556646B2 (en) 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
US6958076B2 (en) 2001-04-16 2005-10-25 Biomedical Research Associates Inc. Implantable venous valve
US7547322B2 (en) 2001-07-19 2009-06-16 The Cleveland Clinic Foundation Prosthetic valve and method for making same
US6562069B2 (en) 2001-09-19 2003-05-13 St. Jude Medical, Inc. Polymer leaflet designs for medical devices
US20030114924A1 (en) 2001-12-18 2003-06-19 Riyad Moe Polymer heart valve
CA2477244A1 (fr) 2002-02-20 2003-08-28 Francisco J. Osse Bivalvule veineuse
US6716241B2 (en) 2002-03-05 2004-04-06 John G. Wilder Venous valve and graft combination
US7160320B2 (en) 2002-04-16 2007-01-09 The International Heart Institute Of Montana Foundation Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support
US7125418B2 (en) 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
US8721713B2 (en) * 2002-04-23 2014-05-13 Medtronic, Inc. System for implanting a replacement valve
US7041132B2 (en) 2002-08-16 2006-05-09 3F Therapeutics, Inc, Percutaneously delivered heart valve and delivery means thereof
GB2407146B (en) 2003-03-20 2006-04-26 Aortech Internat Plc Valve leaflet for use in cardiac valve prosthesis
US8221492B2 (en) 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
US20050075730A1 (en) 2003-10-06 2005-04-07 Myers Keith E. Minimally invasive valve replacement system
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7261732B2 (en) 2003-12-22 2007-08-28 Henri Justino Stent mounted valve
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
EP2526899B1 (fr) 2003-12-23 2014-01-29 Sadra Medical, Inc. Valvule cardiaque repositionnable
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
ITTO20040135A1 (it) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa Protesi valvolare cardiaca
US7445630B2 (en) 2004-05-05 2008-11-04 Direct Flow Medical, Inc. Method of in situ formation of translumenally deployable heart valve support
US20060122693A1 (en) * 2004-05-10 2006-06-08 Youssef Biadillah Stent valve and method of manufacturing same
WO2005118019A1 (fr) 2004-05-28 2005-12-15 Cook Incorporated Structure support de valvule bioabsorbable implantable
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
CA2593652A1 (fr) 2005-01-21 2006-08-17 Innovia, Llc Valvule-stent et catheter de deploiement associe
ITTO20050074A1 (it) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl Protesi valvola cardiaca
US20060200234A1 (en) * 2005-03-03 2006-09-07 Hines Richard A Endovascular aneurysm treatment device and delivery system
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
WO2007016251A2 (fr) 2005-07-28 2007-02-08 Cook Incorporated Valve thromboresistante implantable
US7455689B2 (en) 2005-08-25 2008-11-25 Edwards Lifesciences Corporation Four-leaflet stented mitral heart valve
US8470022B2 (en) 2005-08-31 2013-06-25 Cook Biotech Incorporated Implantable valve
US20070050013A1 (en) 2005-09-01 2007-03-01 Jeffrey M. Gross Venous valve prosthesis and method of fabrication
US7530253B2 (en) 2005-09-09 2009-05-12 Edwards Lifesciences Corporation Prosthetic valve crimping device
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US7648527B2 (en) 2006-03-01 2010-01-19 Cook Incorporated Methods of reducing retrograde flow
US8219229B2 (en) 2006-03-02 2012-07-10 Edwards Lifesciences Corporation Virtual heart valve
CA2653913C (fr) 2006-05-30 2012-04-17 Cook Incorporated Prothese de valve artificielle
ES2432558T3 (es) 2006-06-09 2013-12-04 Eidgenössische Technische Hochschule Zürich Soportes para válvulas cardíacas artificiales y estructuras vasculares
CA2657442A1 (fr) * 2006-06-20 2007-12-27 Aortx, Inc. Valvules cardiaques prothetiques; surtuctures-supports et systemes et methodes d'implantation de ces valvules
US8163011B2 (en) 2006-10-06 2012-04-24 BioStable Science & Engineering, Inc. Intra-annular mounting frame for aortic valve repair
WO2008046092A2 (fr) * 2006-10-13 2008-04-17 Creighton University Prothèse de valve implantable
US9138315B2 (en) 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
EP2192875B1 (fr) 2007-08-24 2012-05-02 St. Jude Medical, Inc. Valvules cardiaques aortiques prothétiques
US20090062907A1 (en) 2007-08-31 2009-03-05 Quijano Rodolfo C Self-expanding valve for the venous system
WO2009045331A1 (fr) 2007-09-28 2009-04-09 St. Jude Medical, Inc. Valvules cardiaques prothétiques repliables/déployables en deux temps et systèmes d'ancrage
US20090138079A1 (en) 2007-10-10 2009-05-28 Vector Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US20090171456A1 (en) * 2007-12-28 2009-07-02 Kveen Graig L Percutaneous heart valve, system, and method
US8628566B2 (en) 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
EP4527348A3 (fr) 2008-01-24 2025-06-11 Medtronic, Inc. Stents pour des valvules cardiaques prothétiques
US8017396B2 (en) 2008-02-22 2011-09-13 Vijay Kumar Cellulose based heart valve prosthesis
US9241792B2 (en) 2008-02-29 2016-01-26 Edwards Lifesciences Corporation Two-step heart valve implantation
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US9061119B2 (en) 2008-05-09 2015-06-23 Edwards Lifesciences Corporation Low profile delivery system for transcatheter heart valve
ES2386239T3 (es) 2008-05-16 2012-08-14 Sorin Biomedica Cardio S.R.L. Prótesis cardiovalvular atraumática
US9061464B2 (en) * 2008-09-03 2015-06-23 Collagen Matrix, Inc. Re-rollable wrapping implant
US9314335B2 (en) 2008-09-19 2016-04-19 Edwards Lifesciences Corporation Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US9119714B2 (en) 2008-10-29 2015-09-01 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer prosthetic medical device
US8556960B2 (en) 2008-11-06 2013-10-15 Cook Medical Technologies Llc Frameless vascular valve
US8808366B2 (en) 2009-02-27 2014-08-19 St. Jude Medical, Inc. Stent features for collapsible prosthetic heart valves
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
EP2246011B1 (fr) 2009-04-27 2014-09-03 Sorin Group Italia S.r.l. Conduit vasculaire prosthétique
US8075611B2 (en) 2009-06-02 2011-12-13 Medtronic, Inc. Stented prosthetic heart valves
EP2509538B1 (fr) * 2009-12-08 2017-09-20 Avalon Medical Ltd. Dispositif et système de remplacement de valvule mitrale transcathéter
US9833314B2 (en) * 2010-04-16 2017-12-05 Abiomed, Inc. Percutaneous valve deployment
US10512537B2 (en) 2010-04-16 2019-12-24 Abiomed, Inc. Flow optimized polymeric heart valve
ES2813091T3 (es) 2010-10-05 2021-03-22 Edwards Lifesciences Corp Válvula cardiaca protésica
US8932343B2 (en) * 2011-02-01 2015-01-13 St. Jude Medical, Cardiology Division, Inc. Blunt ended stent for prosthetic heart valve
GB2488530A (en) * 2011-02-18 2012-09-05 David J Wheatley Heart valve
EP2734152A2 (fr) 2011-07-20 2014-05-28 Boston Scientific Scimed, Inc. Implantation d'une prothèse de valvule cardiaque
US9603707B2 (en) 2011-07-29 2017-03-28 St. Jude Medical, Inc. Dipping mandrel with a gap
US9827093B2 (en) * 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9433991B2 (en) * 2011-12-21 2016-09-06 Edwards Lifesciences Corporation Apparatus and method for stent shaping
US9642700B2 (en) * 2012-05-31 2017-05-09 St. Jude Medical, Cardiology Division, Inc. Prosthetic heart valve having a polymeric stent
WO2014008207A1 (fr) 2012-07-02 2014-01-09 Boston Scientific Scimed, Inc. Formation de prothèse valvulaire cardiaque
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US20140107772A1 (en) 2012-10-12 2014-04-17 St. Jude Medical, Cardiology Division, Inc. Roughened cuff surface
CN105307598B (zh) * 2013-04-19 2017-09-12 海峡接入控股（私人）有限公司 人工心脏瓣膜
EP2991587A4 (fr) 2013-05-01 2016-05-18 Aneumed Inc Prothèse de valvule aortique personnalisée
WO2014209232A1 (fr) 2013-06-25 2014-12-31 National University Of Singapore Élément d'endoprothèse, valve artificielle et procédé d'implantation de cette dernière
US10441415B2 (en) 2013-09-20 2019-10-15 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
WO2015081175A1 (fr) 2013-11-26 2015-06-04 Children's Medical Center Corporation Valve d'endoprothèse extensible
US20170189172A1 (en) 2014-05-06 2017-07-06 Dsm Ip Assets B.V. Method of making a prosthetic valve and valve obtained therewith
EP3139865B1 (fr) 2014-05-07 2025-07-16 Baylor College of Medicine Valves flexibles artificielles
ES2795358T3 (es) 2014-05-16 2020-11-23 St Jude Medical Cardiology Div Inc Sellado subanular para protección de fugas paravalvulares
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
EP3229736B1 (fr) 2014-12-09 2024-01-10 Cephea Valve Technologies, Inc. Valvules cardiaques de remplacement et leur procédé de fabrication
CN109414322B (zh) * 2017-04-07 2021-05-11 上海甲悦医疗器械有限公司 一种人工瓣膜
EP3697345A1 (fr) * 2017-10-23 2020-08-26 Symetis SA Feuillet de valve prothétique
US11202708B2 (en) * 2017-11-08 2021-12-21 The Charles Stark Draper Laboratory, Inc. Segmented, growth-accommodating, artificial valve
US11071626B2 (en) * 2018-03-16 2021-07-27 W. L. Gore & Associates, Inc. Diametric expansion features for prosthetic valves
US20210137676A1 (en) * 2019-11-08 2021-05-13 The Regents Of The University Of California Growth-accommodating valve system

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086612A (en) * 1996-06-24 2000-07-11 Adiam Medizintechnik Gmbh & Co. Kg Mitral valve prosthesis
US20010007956A1 (en) * 1996-12-31 2001-07-12 Brice Letac Valve prosthesis for implantation in body channels
US20030109924A1 (en) * 1996-12-31 2003-06-12 Alain Cribier Implanting a valve prosthesis in body channels
US6171335B1 (en) * 1997-01-24 2001-01-09 Aortech Europe Limited Heart valve prosthesis
US20120277856A1 (en) * 2001-10-11 2012-11-01 Edwards Lifesciences Pvt, Inc. Implantable prosthetic valve
US20080200980A1 (en) * 2006-10-19 2008-08-21 Kevin Robin Profile reduction of valve implant
US20100145435A1 (en) * 2008-02-21 2010-06-10 Valerian Voinov Implantable prosthetic valve stent
US20120053676A1 (en) * 2009-05-07 2012-03-01 Ku David N Implantable Prosthetic Vascular Valves
US20140316516A1 (en) * 2012-01-04 2014-10-23 Tendyne Holdings, Inc. Multi-component cuff designs for transcatheter mitral valve replacement subvalvular sealing apparatus for transcatheter mitral valves and wire framed leaflet assembly

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11464632B2 (en) * 2014-05-07 2022-10-11 Baylor College Of Medicine Transcatheter and serially-expandable artificial heart valve
US11571300B2 (en) * 2014-05-07 2023-02-07 Baylor College Of Medicine Serially expanding an artificial heart valve within a pediatric patient
US11617644B2 (en) 2014-10-13 2023-04-04 W. L. Gore & Associates, Inc. Prosthetic valved conduit
US11351058B2 (en) 2017-03-17 2022-06-07 W. L. Gore & Associates, Inc. Glaucoma treatment systems and methods
US12150897B2 (en) 2017-03-17 2024-11-26 W. L. Gore & Associates, Inc. Delivery aids for glaucoma shunts
US11523940B2 (en) 2017-03-17 2022-12-13 W. L. Gore & Associates, Inc. Delivery aids for glaucoma shunts
US11406533B2 (en) 2017-03-17 2022-08-09 W. L. Gore & Associates, Inc. Integrated aqueous shunt for glaucoma treatment
US20210338422A1 (en) * 2017-09-27 2021-11-04 W. L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
US11986387B2 (en) * 2017-09-27 2024-05-21 Edwards Lifesciences Corporation Prosthetic valves with mechanically coupled leaflets
US12279954B2 (en) 2017-10-31 2025-04-22 W. L. Gore & Associates, Inc. Transcatheter deployment systems and associated methods
US11039919B2 (en) 2017-10-31 2021-06-22 W. L. Gore & Associates, Inc. Valved conduit
US12186182B2 (en) 2017-10-31 2025-01-07 Edwards Lifesciences Corporation Valved conduit
US20200360135A1 (en) * 2017-11-16 2020-11-19 Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
US12004948B2 (en) * 2017-11-16 2024-06-11 Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
CN111818876A (zh) * 2017-11-16 2020-10-23 儿童医学中心公司 几何适应性心脏瓣膜置换装置
US20190343625A1 (en) * 2017-12-11 2019-11-14 Foldax, Inc. Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves
JP7590722B2 (ja) 2017-12-11 2024-11-27 カリフォルニア インスティテュート オブ テクノロジー 血管内埋込可能補綴弁の製造に関するシステム、デバイス、および方法
JP2023100785A (ja) * 2017-12-11 2023-07-19 カリフォルニア インスティテュート オブ テクノロジー 血管内埋込可能補綴弁の製造に関するシステム、デバイス、および方法
CN111801070A (zh) * 2017-12-11 2020-10-20 加州理工学院 与血管内可植入人工瓣膜的制造有关的系统、装置和方法
US11000369B2 (en) * 2017-12-11 2021-05-11 California Institute Of Technolgy Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves
US11478352B2 (en) * 2018-04-09 2022-10-25 Hangzhou Nuoyi Medtech Co., Ltd Venous valve replacement device
CN110353858A (zh) * 2018-04-09 2019-10-22 倍芮医疗器械（上海）有限公司 用于负载瓣膜的支架以及静脉瓣置换装置
US12239573B2 (en) 2018-08-29 2025-03-04 W. L. Gore & Associates, Inc. Drug therapy delivery systems and methods
USD977642S1 (en) 2018-10-29 2023-02-07 W. L. Gore & Associates, Inc. Pulmonary valve conduit
US12364603B2 (en) 2018-12-12 2025-07-22 W. L. Gore & Associates, Inc. Implantable component with socket
US11678983B2 (en) 2018-12-12 2023-06-20 W. L. Gore & Associates, Inc. Implantable component with socket
US12076234B2 (en) 2018-12-13 2024-09-03 Abbott Laboratories Stabilized fabric material for medical devices
US12396845B2 (en) * 2018-12-13 2025-08-26 Abbott Laboratories Fabric material for medical devices
US11547557B2 (en) 2018-12-13 2023-01-10 Abbott Laboratories Stabilized fabric material for medical devices
US20240382326A1 (en) * 2019-02-28 2024-11-21 Renata Medical, Inc. Growth Stent and Valve for Congenital Narrowings
WO2020191386A1 (fr) * 2019-03-21 2020-09-24 The Trustees Of Columbia University In The City Of New York Prothèse transcathéter à tube à valve pour stent polymère biostable et dilatable
US20240423792A1 (en) * 2020-04-24 2024-12-26 ReValve Solutions, Inc. Devices, Systems, and Methods for a Valve Replacement
US20240423791A1 (en) * 2020-04-24 2024-12-26 ReValve Solutions, Inc. Devices, Systems, and Methods for a Valve Replacement
US20240415642A1 (en) * 2020-04-24 2024-12-19 ReValve Solutions Inc. Devices, systems, and methods for a valve replacement
WO2022066961A1 (fr) * 2020-09-23 2022-03-31 ReValve Solutions Inc. Dispositifs, systèmes et procédés pour un adaptateur de valve cardiaque implantable
JP2023545268A (ja) * 2020-10-06 2023-10-27 エドワーズ ライフサイエンシーズ コーポレイション 人工弁用の保護カバー
EP4351477A1 (fr) * 2021-06-07 2024-04-17 Edwards Lifesciences Corporation Feuillets et séparateurs de feuillets pour valves prothétiques
WO2023060330A1 (fr) * 2021-10-15 2023-04-20 Angel Maluf Miguel Prothèse de stent-valve expansible recouverte de polyuréthane avec formation de cuspides anatomiques pour implantation par cathéter en position pulmonaire chez de patients pédiatriques et adultes, et procédé d'obtention de la prothèse de stent-valve expansible
WO2023095033A1 (fr) * 2021-11-23 2023-06-01 Medtronic, Inc. Conception de feuillet pour une prothèse de valve cardiaque
US11969342B2 (en) 2022-08-03 2024-04-30 The Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
EP4378423A1 (fr) * 2022-10-04 2024-06-05 Medtronic Vascular Inc. Prothèse valvulaire à valve prothétique durable
CN116549736A (zh) * 2023-05-29 2023-08-08 哈尔滨工业大学 生物医用织物复合材料薄膜的制备方法

Also Published As

Publication number Publication date
US20200000581A1 (en) 2020-01-02
CA2948179A1 (fr) 2015-11-12
WO2015171743A3 (fr) 2015-12-17
US20230135271A1 (en) 2023-05-04
WO2015171743A2 (fr) 2015-11-12
US11571300B2 (en) 2023-02-07
EP3139865B1 (fr) 2025-07-16
US20220125581A1 (en) 2022-04-28
US20220117731A1 (en) 2022-04-21
EP3139865A4 (fr) 2018-03-28
US11464632B2 (en) 2022-10-11
EP3139865A2 (fr) 2017-03-15
CA2948179C (fr) 2023-08-15

Similar Documents

Publication Publication Date Title
US11464632B2 (en) Transcatheter and serially-expandable artificial heart valve
US20250221820A1 (en) Prosthetic valves, frames and leaflets and methods thereof
JP7393005B2 (ja) 縫合を少なくした置換心臓弁
EP2379322B1 (fr) Structures composites synthétiques
US10548734B2 (en) Venous valve, system, and method with sinus pocket
JP6503454B2 (ja) 置換用心臓弁ならびにそれらの使用および製造の方法
US9827089B2 (en) Methods for improved prosthetic heart valve with leaflet shelving
KR102138396B1 (ko) 인공 심장 판막 첨판에서 굽힘 특성의 기하학적 제어
US10864094B2 (en) Fatigue-resistant flow regulating device and manufacturing methods
US7566343B2 (en) Cardiac valve, system, and method
EP2934389B1 (fr) Valvule cardiaque prothétique à cadres multiples
US9456898B2 (en) Heart valve prosthesis with open stent
EP1977719A2 (fr) Méthode de fabrication d'une prothése valvulaire implantable
EP3644905B1 (fr) Valvule cardiaque prothétique tricuspide
CN104661618B (zh) 瓣膜

Legal Events

Date Code Title Description
STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION